3rd Circ. Stands By Upholding Lipitor Pay-For-Delay Suit Toss
The Third Circuit has refused to rethink its decision backing a New Jersey district court's dismissal of an antitrust suit alleging Ranbaxy Laboratories Ltd. conspired to delay a generic version of the cholesterol...To view the full article, register now.
Already a subscriber? Click here to view full article